                         SEQUENCE LISTING

<110>  Novozymes A/S
 
<120>  Treatment of inflammatory bowel diseases with mammal beta 
       defensins

<130>  11514.204-WO

<160>  6     

<170>  PatentIn version 3.5

<210>  1
<211>  36
<212>  PRT
<213>  Homo sapiens


<220>
<221>  mat_peptide
<222>  (1)..(36)

<400>  1

Asp His Tyr Asn Cys Val Ser Ser Gly Gly Gln Cys Leu Tyr Ser Ala 
1               5                   10                  15      


Cys Pro Ile Phe Thr Lys Ile Gln Gly Thr Cys Tyr Arg Gly Lys Ala 
            20                  25                  30          


Lys Cys Cys Lys 
        35      


<210>  2
<211>  41
<212>  PRT
<213>  Homo sapiens


<220>
<221>  mat_peptide
<222>  (1)..(41)

<400>  2

Gly Ile Gly Asp Pro Val Thr Cys Leu Lys Ser Gly Ala Ile Cys His 
1               5                   10                  15      


Pro Val Phe Cys Pro Arg Arg Tyr Lys Gln Ile Gly Thr Cys Gly Leu 
            20                  25                  30          


Pro Gly Thr Lys Cys Cys Lys Lys Pro 
        35                  40      


<210>  3
<211>  45
<212>  PRT
<213>  Homo sapiens


<220>
<221>  mat_peptide
<222>  (1)..(45)

<400>  3

Gly Ile Ile Asn Thr Leu Gln Lys Tyr Tyr Cys Arg Val Arg Gly Gly 
1               5                   10                  15      


Arg Cys Ala Val Leu Ser Cys Leu Pro Lys Glu Glu Gln Thr Gly Lys 
            20                  25                  30          


Cys Ser Thr Arg Gly Arg Lys Cys Cys Arg Arg Lys Lys 
        35                  40                  45  


<210>  4
<211>  50
<212>  PRT
<213>  Homo sapiens


<220>
<221>  mat_peptide
<222>  (1)..(50)

<400>  4

Glu Phe Glu Leu Asp Arg Ile Cys Gly Tyr Gly Thr Ala Arg Cys Arg 
1               5                   10                  15      


Lys Lys Cys Arg Ser Gln Glu Tyr Arg Ile Gly Arg Cys Pro Asn Thr 
            20                  25                  30          


Tyr Ala Cys Cys Leu Arg Lys Trp Asp Glu Ser Leu Leu Asn Arg Thr 
        35                  40                  45              


Lys Pro 
    50  


<210>  5
<211>  37
<212>  PRT
<213>  Artificial

<220>
<223>  hBD-4 variant consisting of amino acids 3-39 of SEQ ID NO:4


<220>
<221>  mat_peptide
<222>  (1)..(37)

<400>  5

Glu Leu Asp Arg Ile Cys Gly Tyr Gly Thr Ala Arg Cys Arg Lys Lys 
1               5                   10                  15      


Cys Arg Ser Gln Glu Tyr Arg Ile Gly Arg Cys Pro Asn Thr Tyr Ala 
            20                  25                  30          


Cys Cys Leu Arg Lys 
        35          


<210>  6
<211>  40
<212>  PRT
<213>  Mus musculus


<220>
<221>  mat_peptide
<222>  (1)..(40)

<400>  6

Lys Ile Asn Asn Pro Val Ser Cys Leu Arg Lys Gly Gly Arg Cys Trp 
1               5                   10                  15      


Asn Arg Cys Ile Gly Asn Thr Arg Gln Ile Gly Ser Cys Gly Val Pro 
            20                  25                  30          


Phe Leu Lys Cys Cys Lys Arg Lys 
        35                  40  


